Issues of diagnosis and treatment of mild cognitive impairment
https://doi.org/10.21518/2079-701X-2022-16-21-46-53
Abstract
Cognitive impairment refers to frequent disorders in the elderly and senile, and their prevalence increases with age significantly. Non-dementia cognitive disorders mean a spectrum of changes in the cognitive sphere that precede the development of dementia over the course of many months and even years. Mild forms of cognitive impairment (MCI) are the most studied type of pre-dementia conditions, which in most cases represent a prodromal stage of disorders progressing over time to a dementia syndrome. Early identification of individuals with MCI is important because timely diagnosis of these disorders is expanding the potential impact of the secondary prevention and therapeutic intervention, which can delay or even prevent the onset of professional and social maladaptation due to development of dementia. The article considers the historical issues of studying these disorders, presents the modern principles of their classification and diagnostic criteria. A clinical observation of a patient with a polyfunctional non-amnestic type MCI syndrome is provided. The features of cognitive disorders typical for chronic cerebrovascular insufficiency, such as mental retardation, impaired activity arrangement, difficulties with generalisation in relative preservation of memory and orientation in combination with emotional and affective disorders are described. The authors discuss issues of treatment of MCI syndrome, which should be comprehensive and include the correction of all vascular risk factors, non-drug (regular physical activity, cognitive training) and pharmacological treatments aimed at improving cognitive performance. The article describes the possibilities of modern neuroprotective and symptomatic therapy of cognitive impairment, showing the role of choline alfoscerate in the treatment of MCI.
About the Authors
D. A. Grishina
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Dinara A. Grishina, Cand. Sci. (Med.), Assistant of the Department of Nervous Diseases and Neurosurgery of the Medical Faculty
11, Bldg. 1, Rossolimo St., Moscow, 119435
A. B. Lokshina
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Anastasia B. Lokshina, Cand. Sci. (Med.), Assistant of the Department of Nervous Diseases and Neurosurgery of the Medical Faculty
11, Bldg. 1, Rossolimo St., Moscow, 119435
References
1. Парфенов В.А., Захаров В.В., Преображенская И.С. Когнитивные расстройства. М.: Ремедиум; 2014. 192 с. Parfenov V.A., Zakharov V.V., Preobrazhenskaya I.S. Cognitive disorders. Moscow: Remedium; 2014. 192 p. (In Russ.)
2. Яхно Н.Н., Захаров В.В., Локшина А.Б., Коберская Н.Н., Мхитарян Э.А. Деменции. 3-е изд. М.: МЕДпресс-информ; 2011. 374 с. Yakhno N.N., Zakharov V.V., Lokshina A.B., Koberskaya N.N., Mkhitaryan E.A. Dementia. 3rd ed. Moscow: MEDpress-inform; 2011. 374 p. (In Russ.)
3. Rodríguez-Sánchez E., Mora-Simón S., Patino-Alonso M.C., García-García R., Escribano-Hernández A., García-Ortiz L. et al. Prevalence of cognitive impairment in individuals aged over 65 in an urban area: DERIVA study. BMC Neurol. 2011;11:147. https://doi.org/10.1186/1471-2377-11-147.
4. Локшина А.Б., Захаров В.В., Гришина Д.А., Коберская Н.Н., Мхитарян Э.А., Посохов С.И., Яхно Н.Н. Гетерогенность синдрома умеренных когнитивных нарушений (анализ работы специализированного амбулаторного приема). Неврология, нейропсихиатрия, психосоматика. 2021;13(3):34–41. https://doi.org/10.14412/2074-2711-2021-3-34-41. Lokshina A.B., Zakharov V.V., Grishina D.A., Koberskaya N.N., Mkhitaryan E.A., Posohov S.I., Yakhno N.N. Heterogeneity of the mild cognitive impairment syndrome (specialized outpatient service data analysis). Neurology, Neuropsychiatry, Psychosomatics. 2021;13(3):34–41. (In Russ.) https://doi.org/10.14412/2074-2711-2021-3-34-41.
5. Коберская Н.Н., Мхитарян Э.А., Локшина А.Б., Гришина Д.А. Додементные когнитивные расстройства. Российский журнал гериатрической медицины. 2022;(1):48–57. https://doi.org/10.37586/2686-8636-1-2022-48-57. Koberskaya N.N., Mkhitaryan E.A., Lokshina A.B., Grishina D.A. Pre-dementia cognitive impairment. Russian Journal of Geriatric Medicine. 2022;(1):48–57. (In Russ.) https://doi.org/10.37586/2686-8636-1-2022-48-57.
6. Pais R., Ruano L., Moreira C., Carvalho O.P., Barros H. Prevalence and incidence of cognitive impairment in an elder Portuguese population (65–85 years old). BMC Geriatr. 2020;20(1):470. https://doi.org/10.1186/s12877-020-01863-7.
7. Яхно Н.Н., Коберская Н.Н., Захаров В.В., Гришина Д.А., Локшина А.Б., Мхитарян Э.А. и др. Влияние возраста, коморбидных сердечнососудистых и эмоциональных факторов на легкое когнитивное снижение в среднем, пожилом и старческом возрасте. Неврологический журнал. 2018;23(6):309–315. Режим доступа: http://www.medlit.ru/journalsview/nevrojournal/view/journal/2018/issue-6/365-vliyanie-vozrastakomorbidnyh-serdechno-sosudistyh-i-emocional-nyh-faktorov-na-legkoekognitivnoe-snizhenie-v-srednem-pozhilom-i-starcheskom-vozraste. Yakhno N.N., Koberskaya N.N., Zakharov V.V., Grishina D.A., Lokshina A.B., Mkhitaryan E.A. Influence of age, comorbid cardiovascular and emotional factors on mild cognitive decline in middle, old and senile age. Neurological Journal. 2018;23(6):309–315. (In Russ.) Available at: http://www.medlit.ru/journalsview/nevrojournal/view/journal/2018/issue-6/365-vliyanievozrasta-komorbidnyh-serdechno-sosudistyh-i-emocional-nyh-faktorov-nalegkoe-kognitivnoe-snizhenie-v-srednem-pozhilom-i-starcheskom-vozraste.
8. Яхно Н.Н., Коберская Н.Н., Захаров В.В., Гришина Д.А., Локшина А.Б., Мхитарян Э.А. и др. Влияние возрастных, гендерных, коморбидных сердечно-сосудистых и эмоциональных факторов на субъективное когнитивное снижение. Неврологический журнал. 2018;23(4):184–189. Режим доступа: http://www.medlit.ru/journalsview/nevrojournal/view/journal/2018/issue-4/335-vliyanie-vozrastnyh-gendernyh-komorbidnyhserdechno-sosudistyh-i-emocional-nyh-faktorov-na-sub-ektivnoekognitivnoe-snizhenie. Yakhno N.N., Koberskaya N.N., Zakharov V.V., Grishina D.A., Lokshina A.B., Mkhitaryan E.A. Influence of age, gender, comorbid cardiovascular and emotional factors on subjective cognitive decline. Neurological Journal. 2018;23(4):184–189. (In Russ.) Available at: http://www.medlit.ru/journalsview/nevrojournal/view/journal/2018/issue-4/335-vliyanievozrastnyh-gendernyh-komorbidnyh-serdechno-sosudistyh-i-emocionalnyh-faktorov-na-sub-ektivnoe-kognitivnoe-reduction.
9. Яхно Н.Н., Захаров В.В., Коберская Н.Н., Мхитарян Э.А., Гришина Д.А., Локшина А.Б. и др. «Предумеренные» (субъективные и легкие) когнитивные расстройства. Неврологический журнал. 2017;22(4):198–204. Режим доступа: http://www.medlit.ru/journalsview/nevrojournal/view/journal/2017/issue-4/253-predumerennye-sub-ektivnye-i-legkiekognitivnye-rasstroystva. Yakhno N.N., Zakharov V.V., Koberskaya N.N., Mkhitaryan E.A., Grishina D.A., Lokshina A.B. “Premeditated” (subjective and mild) cognitive disorders. Neurological Journal. 2017;22(4):198–204. (In Russ.) Available at: http://www.medlit.ru/journalsview/nevrojournal/view/journal/2017/issue-4/253-predumerennye-sub-ektivnye-i-legkie-kognitivnye-rasstroystva.
10. Petersen R.C., Lopez O., Armstrong M.J., Getchius T.S.D., Ganguli M., Gloss D. et al. Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(3):126–135. https://doi.org/10.1212/WNL.0000000000004826.
11. Яхно Н.Н., Локшина А.Б., Захаров В.В., Гришина Д.А., Коберская Н.Н., Мхитарян Э.А., Посохов С.И. Синдром умеренных когнитивных расстройств в российской популяции. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(5-2):179–180. https://doi.org/10.17116/jnevro201911905S. Yakhno N.N., Lokshina A.B., Zakharov V.V., Grishina D.A., Koberskaya N.N., Mkhitaryan E.A., Posokhov S.I. Mild cognitive impairment syndrome in Russian population. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019;119(5-2):179–180. (In Russ.) https://doi.org/10.17116/jnevro201911905S.
12. Overton M., Pihlsgård M., Elmståhl S. Prevalence and Incidence of Mild Cognitive Impairment across Subtypes, Age, and Sex. Dement Geriatr Cogn Disord. 2019;47(4-6):219–232. https://doi.org/10.1159/000499763.
13. Sachdev P.S., Lipnicki D.M., Kochan N.A., Crawford J.D., Thalamuthu A., Andrews G. et al. The Prevalence of Mild Cognitive Impairment in Diverse Geographical and Ethnocultural Regions: The COSMIC Collaboration. PLoS ONE. 2015;10(11):e0142388. https://doi.org/10.1371/journal.pone.0142388.
14. Захаров В.В. Дофаминергическая и норадренергическая терапия когнитивных нарушений. Журнал неврологии и психиатрии им. С.С. Корсакова. 2006;106(9):43–47. Zakharov V.V. Dopaminergic and noradrenergic therapy of cognitive impairment. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2006;106(9):43–47. (In Russ.)
15. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Kokmen E., Tangelos E.G. Aging, memory, and mild cognitive impairment. Int Psychogeriatr. 1997;9(Suppl. 1):65–69. https://doi.org/10.1017/s1041610297004717.
16. Artero S., Petersen R., Touchon J., Ritchie K. Revised criteria for mild cognitive impairment: validation within a longitudinal population study. Dement Geriatr Cogn Disord. 2006;22(5-6):465–470. https://doi.org/10.1159/000096287.
17. Rao D., Luo X., Tang M., Shen Y., Huang R., Yu J. et al. Prevalence of mild cognitive impairment and its subtypes in community-dwelling residents aged 65 years or older in Guangzhou, China. Arch Gerontol Geriatr. 2018;75:70–75. https://doi.org/10.1016/j.archger.2017.11.003.
18. Захаров В.В., Вознесенская Т.Г. Нервно-психические нарушения: диагностические тесты. 6-е изд. М.: МЕДпреcс-информ; 2018. 320 с. Zakharov V.V., Voznesenskaya T.G. Neuropsychiatric disorders: diagnostic tests. 6th ed. Moscow: MEDpress-inform; 2018. 320 p. (In Russ.)
19. Peters R., Booth A., Rockwood K., Peters J., D’Este C., Anstey K.J. Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis. BMJ Open. 2019;9(1):e022846. https://doi.org/10.1136/bmjopen-2018-022846.
20. Van den Brink A.C., Brouwer-Brolsma E.M., Berendsen A.A.M., van de Rest O. The Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diets Are Associated with Less Cognitive Decline and a Lower Risk of Alzheimer’s Disease-A Review. Adv Nutr. 2019;10(6):1040–1065. https://doi.org/10.1093/advances/nmz054.
21. Zhu Y., Zhong Q., Ji J., Ma J., Wu H., Gao Y. et al. Effects of Aerobic Dance on Cognition in Older Adults with Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2020;74(2):679–690. https://doi.org/10.3233/JAD-190681.
22. Woods B., Aguirre E., Spector A.E., Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. 2012;(2):CD005562. https://doi.org/10.1002/14651858.CD005562.pub2.
23. Giuli C., Fattoretti P., Gagliardi C., Mocchegiani E., Venarucci D., Balietti M. et al. My Mind Project: the effects of cognitive training for elderly-the study protocol of a prospective randomized intervention study. Aging Clin Exp Res. 2017;29(3):353–360. https://doi.org/10.1007/s40520-016-0570-1.
24. Науменко А.А., Преображенская И.С. Когнитивно-моторный тренинг у пациентов с умеренными когнитивными нарушениями и легкой деменцией. Неврология, нейропсихиатрия, психосоматика. 2018;10(4):81–87. https://doi.org/10.14412/2074-2711-2018-4-81-87. Naumenko A.A., Preobrazhenskaya I.S. Cognitive and motor training for patients with moderate cognitive impairment and mild dementia. Neurology, Neuropsychiatry, Psychosomatics. 2018;10(4):81–87. (In Russ.) https://doi.org/10.14412/2074-2711-2018-4-81-87.
25. Ngandu T., Lehtisalo J., Solomon A., Levälahti E., Ahtiluoto S., Antikainen R. et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255–2263. https://doi.org/10.1016/S0140-6736(15)60461-5.
26. Cocchiara R.A., De Lucia F., Koci L., Lisanti E., Petruccini G., La Torre G. Management of the early stage of Alzheimer’s disease: a systematic review of literature over the past 10 years. Clin Ter. 2020;171(4):e357–e368. https://doi.org/10.7417/CT.2020.2239.
27. Matsunaga S., Fujishiro H., Takechi H. Efficacy and Safety of Cholinesterase Inhibitors for Mild Cognitive Impairment: A Systematic Review and MetaAnalysis. J Alzheimers Dis. 2019;71(2):513–523. https://doi.org/10.3233/JAD-190546.
28. Локшина А.Б. Современные аспекты диагностики и лечения синдрома умеренных когнитивных расстройств. Российский журнал гериатрической медицины. 2020;(3):199–204. https://doi.org/10.37586/2686-8636-3-2020-199-204. Lokshina A.B. Modern aspects of diagnosis and treatment of mild cognitive impairment. Russian Journal of Geriatric Medicine. 2020;(3):199–204. (In Russ.) https://doi.org/10.37586/2686-8636-3-2020-199-204.
29. Muratorio A., Bonuccelli U., Nuti A., Bavpistini N., Passero S., Caruso V. et al. A neurotropic approach to the treatment of multi-infarct dementia using l-a-glycerylphosphorylcholine. Curr Ther Res. 1992;52(5):741–752. https://doi.org/10.1016/S0011-393X(05)80518-1.
30. Старчина Ю.А. Применение препарата церетон в неврологической практике. Неврология, нейропсихиатрия, психосоматика. 2011;3(2):81–85. https://doi.org/10.14412/2074-2711-2011-152. Starchina Yu.A. Use of cereton in neurological care. Neurology, Neuropsychiatry, Psychosomatics. 2011;3(2):81–85. (In Russ.) https://doi.org/10.14412/2074-2711-2011-152.
31. Батышева Т.Н., Нестерова О.С., Отческая О.В., Хозова А.А., Зайцев К.С., Камчатнов П.Р., Бойко А.Н. Применение Церетона у больных с умеренными когнитивными расстройствами сосудистого генеза. Трудный пациент. 2009;7(4-5):10–12. Режим доступа: https://www.elibrary.ru/item.asp?id=16908714. Batysheva T.N., Nesterova O.S., Otcheskaya O.V., Khozova A.A., Zaitsev K.S., Kamchatnov P.R., Boyko A.N. The use of Cereton in patients with moderate cognitive disorders of vascular origin. Difficult Patient. 2009;7(4-5):10–12. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=16908714.
32. Пизова Н.В. Опыт применения церетона у больных с хронической ишемией головного мозга и умеренными когнитивными расстройствами. Журнал неврологии и психиатрии им. С.С. Корсакова. 2014;114(12):78–83. https://doi.org/10.17116/jnevro201411412178-83. Pizova N.V. The use of cereton in patients with chronic brain ischemia and moderate cognitive impairment. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2014;114(12):78–83. (In Russ.) https://doi.org/10.17116/jnevro201411412178-83.
33. Левин О.С., Батукаева Л.А., Аникина М.А., Юнищенко Н.А. Эффективность и безопасность холина альфосцерата (Церетона) у пациентов с болезнью Паркинсона с когнитивными нарушениями. Журнал неврологии и психиатрии им. С.С. Корсакова. 2009;109(11):42–46. Режим доступа: https://www.elibrary.ru/item.asp?id=13123642. Levin O.S., Batukaeva L.A., Anikina M.A., Yunischenko N.A. Efficacy and safety of choline alfoscerate (Cereton) in patients with Parkinson’s disease with cognitive impairment. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2009;109(11):42–46. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=13123642.
34. Вахнина Н.В., Милованова О.В. Неврологические расстройства у пациентов с артериальной гипертензией и их коррекция. Неврология, нейропсихиатрия, психосоматика. 2016;8(4):32–37. https://doi.org/10.14412/2074-2711-2016-4-32-37. Vakhnina N.V., Milovanova O.V. Neurological disorders in patients with hypertension and their correction. Neurology, Neuropsychiatry, Psychosomatics. 2016;8(4):32–37. (In Russ.) https://doi.org/10.14412/2074-2711-2016-4-32-37.
35. Антоненко Л.М., Вахнина Н.В., Громова Д.О. Когнитивные нарушения, головокружение и неустойчивость у пациентов с артериальной гипертензией. Неврология, нейропсихиатрия, психосоматика. 2020;12(5):92–97. https://doi.org/10.14412/2074-2711-2020-5-92-97. Antonenko L.M., Vakhnina N.V., Gromova D.O. Cognitive impairment, dizziness, and unsteadiness in hypertensive patients. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(5):92–97. (In Russ.) https://doi.org/10.14412/2074-2711-2020-5-92-97.
36. Гришина Д.А. Нейропсихологическая диагностика и лечение пациентов с деменцией. Медицинский совет. 2018;(18):16–22. https://doi.org/10.21518/2079-701X-2018-18-16-22. Grishina D.A. Neuropsychological testing in the diagnosis and management of patients with dementia. Meditsinskiy Sovet. 2018;(18):16–22. (In Russ.) https://doi.org/10.21518/2079-701X-2018-18-16-22.
Review
For citations:
Grishina DA, Lokshina AB. Issues of diagnosis and treatment of mild cognitive impairment. Meditsinskiy sovet = Medical Council. 2022;(21):46-53. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-21-46-53
Views:
525
Email this article 